MONOPHARMA Share Price Performance
₹24.15
-15.10 (-38.47%)
Price ₹24.15
Share Price₹24.15
MONOPHARMA Community Narratives
There are no narratives available yet.
Recent MONOPHARMA News & Updates
No updates
Mono Pharmacare Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.75
- Gross Margin
- 10.04%
- Net Profit Margin
- 1.83%
- Debt/Equity Ratio
- 171.5%
Mono Pharmacare Limited Competitors
About MONOPHARMA
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Mono Pharmacare Limited engages in the marketing and distribution of pharmaceutical products in India. The company offers products in various categories, such as antibiotics, anti-fungal, anti cough- cold and anti-allergic, antacid and antiemetics, analgesic and antipyretic, nutraceuticals, skin care, antiseptic, cardiac and diabetics, cosmetics, etc. It also sells its pharmaceutical products under the DLS Export brand name. The company was founded in 1994 and is based in Ahmedabad, India.
Indian Market Performance
- 7 Days: 0.2%
- 3 Months: 5.2%
- 1 Year: -2.4%
- Year to Date: -1.1%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Similarly, the market is flat for the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading